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Abstract
Cystic pancreatic lesions (CPLs) are detected with increasing frequency. Endoscopic ultrasound (EUS) may provide detailed
imaging of the CPLs. Additional diagnostic information may be obtained with EUS-guided ﬁne-needle aspiration of the cyst
contents and the subsequent cyst ﬂuid analysis and cytology. This article is part of an expert video encyclopedia.
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Video Related to this Article
Techniques
• Endoscopic ultrasound (EUS).
• Fine-needle aspiration (FNA).
Materials
• Echoendoscope: Linear echoendoscope; Pentax, Montvale,
NJ, USA.
• Accessories: EchoTips Ultra High Deﬁnition Ultrasound
Access Needle; Cook Medical Inc., Bloomington, IN, USA.
Background and Endoscopic Procedure
Cystic pancreatic lesions (CPLs) are being detected with in-
creasing frequency.1 Up to 60% of CPLs are reported to be
pancreatic cystic neoplasms (PCNs).2 The four major types of
PCNs are intraductal papillary mucinous neoplasm (IPMN),
mucinous cystic neoplasm (MCN), serous cystic neoplasm
(SCN), and solid-pseudopapillary neoplasm (SPN).3
There are some cross-sectional imaging features that are
characteristic for certain PCNs. For main-duct IPMNs, the
main pancreatic duct is cystically dilated.4 In branch-duct
IPMNs, the cystically dilated branch ducts communicate with
the main pancreatic duct.4 Peripheral calciﬁcation on com-
puted tomography is nearly speciﬁc for MCN.5 Honeycombed
or microcystic lesion with a central scar with calciﬁcation is
diagnostic of SCN.6,7
On EUS, the ﬁndings that suggest IPMN include dilation of
the main pancreatic duct or branch duct(s) with or without
mural nodules and intraluminal debris or mucus.8 MCNs
appear as thin-walled, septated, ﬂuid-ﬁlled cavities. SCNs
typically appear as multiple well-demarcated microcystic le-
sions with septations.9 SPNs may appear to be solid, mixed
solid and cystic, or cystic on EUS. Some SPNs may have
calciﬁcations.10
EUS-guided FNA (EUS–FNA) is a versatile tool in the
evaluation of CPLs. It may provide the specimen for cyst ﬂuid
analysis and cytology. Cyst ﬂuid carcinoembryonic antigen
concentration is the most accurate marker of mucinous CPLs
(i.e., IPMN and MCN).11,12 Cytology is reported to be the best
test to diagnose malignant cysts.12
Key Learning Points/Tips and Tricks
• The movement of the needle is easier when the echoen-
doscope is straight.
• Scan the needle pathway using color Doppler mode to
identify and avoid vascular structures.
• Always keep the needle in the visual plane during
EUS–FNA.
• Aspirate all ﬂuid, make one needle pass, and use antibiotics
in order to minimize the risk of cyst infection.
Complication and Risk Factors
The complication rate of EUS–FNA of CPLs is low. In one
large-scale report, the overall complication rate was 2.2% (13
of 603 patients), with no obvious identiﬁable risk factors. The
reported complications were pancreatitis (n¼6), abdominal
pain (n¼4), retroperitoneal bleeding (n¼1), infection (n¼1),
and bradycardia (n¼1).13
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Scripted Voiceover
Time
(min:sec)
Voiceover text
00:03 Cystic pancreatic lesions are being detected with
increasing frequency. Most of these lesions are
pancreatic cystic neoplasms. Intraductal papillary
mucinous neoplasm, mucinous cystic neoplasm,
serous cystic neoplasm, and solid-pseudopapillary
neoplasm account for the majority of pancreatic
cystic neoplasms.
00:28 In main-duct IPMNs, the main pancreatic duct is
cystically dilated, as can be seen in the CT and MRCP.
00:38 On EUS, the main pancreatic duct is dilated with or
without mural nodules and intraluminal debris or
mucus.
00:48 On resected specimen, notice the dilated main
pancreatic duct,
00:53 and notice the tumor at the head of the pancreas.
00:58 In branch-duct IPMNs, the branch duct is cystically
dilated. MRCP may show the communication between
the branch-duct IPMN and the main pancreatic duct.
01:10 On EUS, the branch duct is cystically dilated.
Occasionally the communication between the cystic
lesion and the main pancreatic duct may be
demonstrated.
01:22 On resected specimen, the branch duct is cystically
dilated. The lesions form multi-cystic, grape-like
structures.
01:30 Microscopically, IPMNs show intraductal proliferation
of columnar mucin-producing cells. The epithelium
can be ﬂat or papillary.
01:42 In some cases of IPMNs, duodenoscopy may reveal a
patulous duodenal papilla and mucin extrusion
through the oriﬁce.
01:53 Mucinous cystic neoplasms are predominantly
macrocystic. Septations may be present, which may
be more conspicuous on MRI.
02:02 Peripheral calciﬁcation on CT is nearly speciﬁc for
mucinous cystic neoplasm.
02:08 On EUS, mucinous cystic neoplasm may be uniocular,
or septated.
02:15 The resected specimen may be uniocular or septated.
The internal surface of the specimen shown is
glistening with mucin. Mural nodules are also seen.
02:27 Histologically, mucinous cystic neoplasms are
characterized by ovarian-type stroma, composed of
densely packed spindle cells with sparse cytoplasm
and uniform, elongated nuclei. The presence of
ovarian-type stroma is a requirement for diagnosis.
02:45 EUS-FNA or IPMN or mucinous cystic neoplasm may
reveal thick, mucinous cyst ﬂuid.
02:54 The ﬂuid is usually high in CEA concentration,
and cytology may reveal mucinous
glandular cells, as seen in the inset photomicrograph.
03:07 Serous cystic neoplasms are usually polycystic. The
central nidus often calciﬁes, as seen on the pre-
contrast CT.
03:16 EUS shows the characteristic microcystic nature of a
serous cystic neoplasm.
03:22 EUS-FNA of serous cystic neoplasm may reveal thin and
nonmucinous cyst ﬂuid.
03:29 The ﬂuid is usually low in CEA concentration, and
cytology may reveal cuboidal cells with small round
nuclei and clear cytoplasm.
03:40 This is a characteristic gross appearance of serous
cystic neoplasm. The lesion is composed of
numerous tiny cysts. The cysts are arranged around a
central, ﬁbrous scar. The central scar may be
calciﬁed, as in this case.
03:57 Histologically, serous cystic neoplasms are lined by a
single layer of cuboidal epithelial cells.
04:07 A solid-pseudopapillary neoplasm is seen on CT, which
is a heterogeneous, partially solid and partially cystic
mass.
04:17 Calciﬁcations may be seen occasionally, as seen on this
CT of another patient.
04:24 On EUS, solid-pseudopapillary neoplasm may be solid,
mixed solid and cystic, or cystic. Here we see a cystic
lesion with septation.
04:35 The cyst ﬂuid of a solid-pseudopapillary neoplasm is
usually low in CEA concentration, and cytology may
be highly cellular with monotonous sheets of densely
packed cells.
04:48 Solid-pseudopapillary neoplasms are usually large,
round, and solitary. Cut section of solid-
pseudopapillary neoplasm reveals solid areas that are
lobulated and light brown to yellow in color. There
may also be zones of hemorrhage and necrosis. The
cystic spaces may be ﬁlled with necrotic debris.
05:11 The solid portions of solid-pseudopapillary neoplasm
are composed of poorly cohesive monomorphic cells.
These cells are admixed with hyalinized or myxoid
stromal bands. Pseudopapillae are formed when the
poorly cohesive neoplastic cells drop away.
05:28 Here are some tips and tricks for EUS-FNA of cystic
pancreatic lesions.
05:35 The movement of the needle is easier when the
echoendoscope is straight. Always try to maintain the
echoendoscope as straight as possible.
05:45 Scan the needle pathway using color Doppler mode to
identify and avoid vascular structures.
05:55 Always keep the needle in the visual plane during EUS-
FNA.
06:04 Aspirate all ﬂuid, make one needle pass, and use
antibiotics in order to minimize the risk of cyst
infection.
06:18 In summary, cystic pancreatic lesions are being
detected with increasing frequency.
Pancreatic cystic neoplasms account for the majority of
these lesions.
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06:29 EUS may provide detailed imaging of cystic pancreatic
lesions.
Analysis of cyst ﬂuid may aid the differential diagnosis
of these lesions.
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